Skip to main content

and
  1. No Access

    Article

    Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm

    To summarize and discuss the available evidence and ongoing efforts in order to establish the efficacy and safety of immunotherapeutic approaches in HER2-positive breast cancer.

    Jesús Soberino, Fabricio Racca, José Pérez-García in Current Breast Cancer Reports (2019)